Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cholinomimetic treatment fails to improve memory disorders.

Literature DB >> 7402228

Cholinomimetic treatment fails to improve memory disorders.

E D Caine.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1980 PMID： 7402228 DOI： 10.1056/nejm198009043031019

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

Review 1. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors: M Sarter; J Hagan; P Dudchenko
Journal: Psychopharmacology (Berl) Date: 1992 Impact factor: 4.530

2. A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.

Authors: S B Freedman; E A Harley; S Patel; N R Newberry; M J Gilbert; A T McKnight; J K Tang; J J Maguire; N T Mudunkotuwa; R Baker
Journal: Br J Pharmacol Date: 1990-11 Impact factor: 8.739

Review 3. Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders.

Authors: Chad R Johnson; Brian D Kangas; Emily M Jutkiewicz; Jack Bergman; Andrew Coop
Journal: Biomedicines Date: 2022-02-07

4. Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease.

Authors: T T Soncrant; K C Raffaele; S Asthana; A Berardi; P P Morris; J V Haxby
Journal: Psychopharmacology (Berl) Date: 1993 Impact factor: 4.530

5. Therapeutic effect of THA on hemicholinium-3-induced learning impairment is independent of serotonergic and noradrenergic systems.

Authors: J J Hagan; J H Jansen; F E Nefkens; T de Boer
Journal: Psychopharmacology (Berl) Date: 1990 Impact factor: 4.530

Cholinomimetic treatment fails to improve memory disorders.

Review 1. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

2. A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.

Review 3. Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders.

4. Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease.

5. Therapeutic effect of THA on hemicholinium-3-induced learning impairment is independent of serotonergic and noradrenergic systems.

Review 6. Tetrahydroaminoacridine (THA) in Alzheimer's disease.

Review 7. Recent advances in geriatric psychopharmacology.

8. Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics.